Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale
- PMID: 17374952
- DOI: 10.1159/000100973
Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale
Abstract
Background/aims: The status of imaging findings in the clinical diagnosis of frontotemporal dementia (FTD) remains uncertain; while they may be supportive of a diagnosis of frontotemporal dementia, they are not mandatory. Our aim was to assess patterns of lobar atrophy in a large sample of clinically defined, prospectively studied, patients using a magnetic resonance image (MRI) rating scale, to (1) determine whether imaging findings warrant a more prominent position in FTD diagnosis and (2) correlate the extent of lobar atrophy with clinical data.
Methods: We adapted a recently devised post mortem rating scale for FTD to rate lobar atrophy on MRI scans. The areas rated included the frontal cortex and both anterior and posterior temporal regions bilaterally. All available brain scans from all patients seen in the Cambridge Dementia Clinic (n = 258) diagnosed as having FTD, together with controls (n = 20), were used to assess the reliability of the method. A subset of these (n = 121) were used for clinico-anatomic analysis.
Results: The scale proved quick and reliable (intra-, inter-rater k = 0.80, 0.67). MRI scans were abnormal in the majority of patients (75%), with focal atrophy present in 100% of semantic dementia (SD) patients. By contrast, nearly half (47%) of the patients with clinical behavioural variant FTD had scans within the normal range. Behavioural cases with normal scans generally had fewer cognitive deficits and milder functional impairment than those with abnormal scans, yet displayed a clinically indistinguishable behavioural syndrome. They were not, however, simply at an earlier stage of the disease.
Conclusions: MRI findings should form part of the diagnostic criteria for SD; the absence of atrophy on MRI in many behavioural cases raises the prospect that the behavioural syndrome of FTD is not specific for patients with a neurodegenerative disease.
Copyright 2007 S. Karger AG, Basel.
Similar articles
-
Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia.J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):165-73. doi: 10.1136/jnnp.70.2.165. J Neurol Neurosurg Psychiatry. 2001. PMID: 11160463 Free PMC article.
-
Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.Neurology. 2009 May 12;72(19):1653-60. doi: 10.1212/WNL.0b013e3181a55fa2. Neurology. 2009. PMID: 19433738 Free PMC article.
-
Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease.Dement Geriatr Cogn Disord. 2006;21(5-6):364-72. doi: 10.1159/000091838. Epub 2006 Mar 3. Dement Geriatr Cogn Disord. 2006. PMID: 16534206
-
Lobar atrophy in frontotemporal dementia: diagnostic and prognostic implications.Curr Alzheimer Res. 2011 May;8(3):261-5. doi: 10.2174/156720511795563818. Curr Alzheimer Res. 2011. PMID: 21222601 Review.
-
[Diagnosing frontotemporal dementia, a chameleon in psychiatry].Tijdschr Psychiatr. 2006;48(9):705-15. Tijdschr Psychiatr. 2006. PMID: 17007476 Review. Dutch.
Cited by
-
Evaluation of Ultrafast Wave-CAIPI MPRAGE for Visual Grading and Automated Measurement of Brain Tissue Volume.AJNR Am J Neuroradiol. 2020 Aug;41(8):1388-1396. doi: 10.3174/ajnr.A6703. Epub 2020 Jul 30. AJNR Am J Neuroradiol. 2020. PMID: 32732274 Free PMC article.
-
Incidence of frontotemporal disorders in Olmsted County: A population-based study.Alzheimers Dement. 2020 Mar;16(3):482-490. doi: 10.1016/j.jalz.2019.08.199. Epub 2020 Jan 4. Alzheimers Dement. 2020. PMID: 31784373 Free PMC article.
-
Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY).Alzheimers Res Ther. 2018 Sep 27;10(1):102. doi: 10.1186/s13195-018-0427-2. Alzheimers Res Ther. 2018. PMID: 30261917 Free PMC article. Clinical Trial.
-
Exploring quantitative group-wise differentiation of Alzheimer's disease and behavioural variant frontotemporal dementia using tract-specific microstructural white matter and functional connectivity measures at multiple time points.Eur Radiol. 2019 Oct;29(10):5148-5159. doi: 10.1007/s00330-019-06061-7. Epub 2019 Mar 11. Eur Radiol. 2019. PMID: 30859283 Free PMC article.
-
Detecting frontotemporal dementia syndromes using MRI biomarkers.Neuroimage Clin. 2019;22:101711. doi: 10.1016/j.nicl.2019.101711. Epub 2019 Feb 4. Neuroimage Clin. 2019. PMID: 30743135 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical